Prudential Financial
KURA icon

Prudential Financial’s Kura Oncology KURA Stock Holding History

Prudential Financial’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.94M Buy
267,950
+226,670
+549% +$2.14M ﹤0.01% 1243
2026
Q1 		$336K Sell
41,280
-50,920
-55% -$437K ﹤0.01% 1988
2025
Q4 		$958K Buy
92,200
+8,452
+10% +$88.7K ﹤0.01% 1610
2025
Q3 		$741K Buy
+83,748
New +$597K ﹤0.01% 1773
2024
Q3 		– Sell
-18,277
Closed -$376K – 2758
2024
Q2 		$376K Buy
18,277
+940
+5% +$19.3K ﹤0.01% 2290
2024
Q1 		$370K Buy
+17,337
New +$337K ﹤0.01% 2274
2021
Q1 		– Sell
-6,627
Closed -$216K – 2515
2020
Q4 		$216K Buy
+6,627
New +$233K ﹤0.01% 2341
2020
Q2 		– Sell
-17,694
Closed -$176K – 2436
2020
Q1 		$176K Sell
17,694
-49,399
-74% -$565K ﹤0.01% 2203
2019
Q4 		$923K Buy
67,093
+471
+0.7% +$6.98K ﹤0.01% 1886
2019
Q3 		$1.01M Buy
+66,622
New +$1.19M ﹤0.01% 1850

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Prudential Financial's KURA Position: Q2 2026 in Review

Prudential Financial increased its Kura Oncology (KURA) stake by 549% in Q2 2026, buying an estimated $2.14M and bringing the position to 267,950 shares worth $2.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1243.

Prudential Financial first reported a position in KURA in Q3 2019 and has held it in 10 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Prudential Financial held 267,950 shares of Kura Oncology worth $2.94M as of Q2 2026.
  • Prudential Financial bought 226,670 Kura Oncology shares in Q2 2026, an estimated $2.14M.
  • Kura Oncology made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1243 holding.
  • Prudential Financial first reported a position in Kura Oncology in Q3 2019 and has held it in 10 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.